Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (211-220 of 385) with videos related to

Pageof 39
Sort By:
Oncotarget|December 10, 2017
Analysis of <i>NPM1</i> splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemiaMalgorzata Zajac, Anna Dolnik, Grazyna Stasiak, et al.
British Journal of Haematology|June 20, 2008
Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysisTiemo Katzenberger, Dirk Kienle, Stephan Stilgenbauer, et al.
Blood Advances|May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaStephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
Haematologica|February 1, 2024
Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and researchSimone Oerlemans, Belle H De Rooij, Christine Bennink, et al.
Haematologica|July 18, 2020
Endothelial damage and dysfunction in acute graft-versus-host diseaseSteffen Cordes, Zeinab Mokhtari, Maria Bartosova, et al.
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Frontiers in Immunology|March 2, 2023
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantationBenedikt Obermayer, Luisa Keilholz, Thomas Conrad, et al.
Leukemia|November 18, 2022
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemiaVictoria Y Ling, Jasmin Straube, William Godfrey, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Blood|September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutisLivius Penter, Katie Maurer, Nicoletta Cieri, et al.
Pageof 39

Showing results (211-220 of 385) with videos related to

Sort By:
Pageof 39
Oncotarget|December 10, 2017
Analysis of <i>NPM1</i> splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemiaMalgorzata Zajac, Anna Dolnik, Grazyna Stasiak, et al.
British Journal of Haematology|June 20, 2008
Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysisTiemo Katzenberger, Dirk Kienle, Stephan Stilgenbauer, et al.
Blood Advances|May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaStephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
Haematologica|February 1, 2024
Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and researchSimone Oerlemans, Belle H De Rooij, Christine Bennink, et al.
Haematologica|July 18, 2020
Endothelial damage and dysfunction in acute graft-versus-host diseaseSteffen Cordes, Zeinab Mokhtari, Maria Bartosova, et al.
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Frontiers in Immunology|March 2, 2023
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantationBenedikt Obermayer, Luisa Keilholz, Thomas Conrad, et al.
Leukemia|November 18, 2022
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemiaVictoria Y Ling, Jasmin Straube, William Godfrey, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Blood|September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutisLivius Penter, Katie Maurer, Nicoletta Cieri, et al.
Pageof 39